ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally
invasive medical devices for vascular access, surgery, peripheral
vascular disease and oncology, today announced that it will report its
fiscal 2011 fourth quarter and full year financial results on Thursday,
July 14, 2011, after the close of the U.S. financial markets.
Scott Solano, AngioDynamics' interim Chief Executive Officer, and Joseph
Gersuk, Executive Vice President and Chief Financial Officer, will host
an investment community conference call beginning at 4:30 p.m. Eastern
Time on July 14, 2011, to discuss the results and to answer questions.
To participate in the live call by telephone, please dial +1 (877)
941-6009.
Those interested in listening to the conference call live via the
Internet may do so by visiting the Investor Relations section of
AngioDynamics' Web site at http://investors.angiodynamics.com.
To listen to the live call, please go to the Web site 15 minutes prior
to its start to register, download and install the necessary audio
software. The conference call will also be archived on the Web site.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative, minimally
invasive medical devices used by professional healthcare providers for
vascular access, surgery, peripheral vascular disease and oncology.
AngioDynamics' diverse product lines include market-leading ablation
systems, vascular access products, angiographic products and
accessories, angioplasty products, drainage products, thrombolytic
products, embolization products and venous products. More information is
available at www.angiodynamics.com.
Company Contact:
AngioDynamics, Inc.
D.
Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
Investor
Relations Contacts:
EVC Group, Inc.
Doug
Sherk, 415-568-4887
dsherk@evcgroup.com
Greg
Gin, 646-445-4801
ggin@evcgroup.com
or
Media
Contact:
EVC Group, Inc.
Chris
Gale, 646-201-5431
cgale@evcgroup.com
Source: AngioDynamics, Inc.
News Provided by Acquire Media
